Sponsored Links

 

Displaying anti vegf PowerPoint Presentations



Increasing use of anit-VEGF in Ophthalmology PPT

Presentation Summary : increasing use of anti vegf in ocular conditions – indications, technique & limitations dr. rahul shukla m.s., dnb, mnams t.n shukla eye hospital

Source : http://www.jdosmp.org/pps/antiVEGF_rs.ppt

Patterns of practice of antivegf injections among ophthalmologist PPT

Presentation Summary : INTRODUCTION. Anti-VEGF injections have changed the face of both medical and surgical retina practice world wide. These agents are being used for many eye diseases ...

Source : http://www.eyefoundationhospital.com/assets/files/Patterns%20of%20practice%20of%20antivegf%20injections%20among%20ophthalmologist.pptx

Slide 1 PPT

Presentation Summary : VEGF-A, VEGF-B, and PlGF are involved in multiple pathways of angiogenic response. ENDOTHELIAL CELL. Survival, Migration, Proliferation. VEGF-A. VEGFR-1

Source : http://imedex.com/metastatic-colorectal-cancer-with-antiangiogenic-agents/assets/presentations/Lenz_ASCO_ASCO_CME_lenz%20_mesd.pptx

Angiogenesis and Metastases PPT

Presentation Summary : Targeting Tumor Angiogenesis: What Have We Learned So Far? Lee M. Ellis, MD Departments of Cancer Biology and Surgical Oncology UT MD Anderson Cancer Center

Source : http://www.gislides.com/gislides/ASCO_2010_files/Ellis%20Angiogenesis%20Educ%20ASCO%202010.ppt

Lucentis™: The Only Anti-VEGF Treatment to Improve Vision PPT

Presentation Summary : Title: Lucentis™: The Only Anti-VEGF Treatment to Improve Vision Author: ldetulleo Last modified by: Julie Fotheringham Created Date: 3/21/2008 7:27:05 PM

Source : http://macuscope.com/MacuScopepptforWebsite.ppt

35 mm - University of Pennsylvania PPT

Presentation Summary : Pharmacogenetics for Genes Associated with Age-Related Macular Degeneration in the Comparison of AMD Treatments Trials (CATT) Hagstrom SA, Ying G-S, Pauer GJT ...

Source : http://faculty.vet.upenn.edu/cpob/studies/documents/PharmacogenticsofAnti-VEGFinCATTHagstromFIGURES_001.ppt

Title of article PPT

Presentation Summary : JAMA Ophthalmology Journal Club Slides: VEGFA and VEGFR1 and Response to Anti-VEGF Hagstrom SA, Ying G, Pauer GJT, et al; Comparison of Age-Related Macular ...

Source : http://archopht.jamanetwork.com/data/Journals/OPHTH/0/EOI140009slidea_prod.ppt

Slide 1 PPT

Presentation Summary : Update on Anti-VEGF Therapy in Diabetic Macular Edema, Neovascular AMD, and Retinal Vein Occlusion Jonathan S. Chang, MD Bascom Palmer Eye Institute, University of ...

Source : http://www.theophthalmologyreport.com/slides/Chang.ppt

PowerPoint Presentation PPT

Presentation Summary : Retinal Edema & Mode of action of anti-VEGF therapies * * A VEGF blockade provides three complementary mechanisms of action for the treatment of AMD.9 It is: Anti ...

Source : http://www.kashyapmemorialeyehospital.com/Retinal%20Diseases,%20Lasers%20&%20Intra%20Vitreal%20Ozurdex,%20Lucentis/Intra%20Vitreal%20Injections/Intra%20Vitreal%20Lucentis%20&%20Ozurdex%20injections/2%20Retina%20Edema%20&%20Intra%20Vitreal%20Lucentis%20Injection.ppt

Angiogenesis and Angiogenesis Inhibition: Strategies and ... PPT

Presentation Summary : Title: Angiogenesis and Angiogenesis Inhibition: Strategies and Prospects Author: Indiana University Last modified by: Administrator Created Date

Source : http://www.bcirg.org/NR/rdonlyres/ehqq5o377v52u25pw6pckheycgcbg42s4362ujn4vryczjrkqetrxqexbmiobjxtvsrufadu2gzbget7dlc64czsgld/DR.Sledge.ppt

Challenges in translating anti-angiogenic therapy from the ... PPT

Presentation Summary : ASCO 2005 “Advancing the science of clinical oncology” Anti-VEGF Therapy Goes Mainstream Lee M. Ellis, MD UT MD Anderson Cancer Center Houston, TX

Source : http://www.gislides.com/gislides/2005_files/Ellis%20-Discussant%20Plenary%20angiogenesis.ppt

ANTI-CANCER THERAPY - Web Publishing - SMU PPT

Presentation Summary : ANTI-CANCER THERAPY MONOCLONAL ANTIBODIES BY: FIROUZEH KAMALI ... PDGFR (platelet-derived growth factor receptor) VEGFR (vascular endothelial growth factor) ...

Source : http://faculty.smu.edu/jbuynak/ANTI-CANCER%20THERAPY.ppt

Funding Mechanism PPT

Presentation Summary : Anti-VEGF+Deferred PRP may receive PRP only if failure/futility criteria are met Protocol chair approval MUST be obtained before PRP is given in some cases of ...

Source : http://publicfiles.jaeb.org/drcrnet/presentations/Protocol_S_Summary_Slides_2_21_12.ppt

Introducing Integrin Peptide TherapyTM for the treatment of ... PPT

Presentation Summary : Sharing Your Vision™ Current approach is anti-VEGF, whether it is Lucentis, Avastin, VEGF Trap ALG-1001 has a completely different MOA – working upstream to shut ...

Source : http://www.irvineecondev.com/uploads/misc/allegro.ppt

Early Detection of Cardiotoxicity During Chemotherapy Using ... PPT

Presentation Summary : Anti-VEGF Therapy can decrease blood flow resulting in cancer control You are only as good as your endothelium (or your small vessels ...

Source : http://www.mdanderson.org/education-and-research/resources-for-professionals/clinical-tools-and-resources/ccop-research-base/multimedia-resources-and-downloads/saturday-am-lenihan-multicenter-study-of-biomarkers-during-chemotherapy-printed.ppt

Vascular Endothelial Growth Factor PPT

Presentation Summary : Title: Vascular Endothelial Growth Factor Author: Michael Mathieu Last modified by: Maria Schaefer Created Date: 2/24/2004 8:25:45 PM Document presentation format

Source : http://www.colorectalcancerupdate.com/nsabp_symposium/ppt/NSABP06Hochster.ppt

Funding Mechanism - Jaeb PPT

Presentation Summary : ... confirmed at 2 consecutive 4-week visits * Prompt laser + deferred anti-VEGF Observation + deferred anti-VEGF At least one eye meeting all of the following ...

Source : http://publicfiles.jaeb.org/DRCRPresentationOverview2_20_14final.ppt

Inhibiting the VEGF Pathway in Kidney Cancer PPT

Presentation Summary : Greenebaum Cancer Center VEGF expression is regulated by a number of factors ... Therapeutic inhibition of VEGF in RCC Miscellaneous anti-VEGF agents Thalidomide ...

Source : http://www.umgcc.org/research/presentations/dawson_targeted_therapy.ppt

Update on EGFR Monoclonal Antibody Therapy in Metastatic ... PPT

Presentation Summary : ... anti-VEGF therapy and Cetuximab Data presently do not support routine use of EGFR mAb therapy in combination with chemotherapy +/- anti-VEGF therapy in first ...

Source : http://l39gg632kcb0ewpfj-sites-default-files.s3.amazonaws.com/DefiningTheRoleOfEGFRMonoclonalAntibodyTherapyInMetastaticv2.ppt

Slide 1 PPT

Presentation Summary : Retinal Vein Occlusion 2010 An Evidence-Based Approach Corticosteroids, Implants, and Anti VEGF Therapies Allen C. Ho, MD Professor of Ophthalmology

Source : http://www.aao.org/newsroom/meeting/upload/AC-Ho-aao-2010_Vein-Occlusion-Studies.ppt

Understanding SNPs and Cancer - National Cancer Institute PPT

Presentation Summary : Included in this category are anti-VEGF antibodies that block the VEGF ... Signaling Cascade Genes are activated in cell nucleus Cancer cell VEGF ...

Source : http://www.cancer.gov/SharedItems/Powerpoints/ANGIOGEN.PPT

PowerPoint Presentation PPT

Presentation Summary : Initiating phase 1 clinical trials in ... anti-VEGF agents SU5416 rhuMB-VEGF Neovastat IM862 PTK787A Aplidine Angiozyme ZD6474 SU6668 SMART Anti-VEGF IMC ...

Source : http://www.fda.gov/ohrms/dockets/ac/02/slides/3899S1_10_Anderson.ppt

Sponsored Links

Report a violation: If you find a presentation that is using one of your presentation without permission, contact us immidiately at

© XPowerPoint.com